Related Experiment Video
Updated: Jan 26, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
Role of Cytomorphology in the Era of Liquid Biopsy
Eduardo Clery1, Pasquale Pisapia1, Elena Vigliar1
1Department of Public Health, University of Naples Federico II, Naples, Italy.
Abstract:
In the late stages of non-small cell lung cancer, the detection of sensitizing mutations of the epidermal growth factor receptor (EGFR) is mandatory to select patients' treatment with first- or second-generation tyrosine kinase inhibitors (TKIs). In patients showing progressive disease, the assessment of the EGFR exon 20 resistance point mutation p.T790M is required for third-generation TKI administration. However, molecular analysis does not capture all the different mechanisms of resistance against these molecules. A variety of morphological changes associated with acquired resistance have also been described. Since an altered morphology may be the only clue to acquired resistance, cytopathology still plays a relevant role in this setting. In this comprehensive review, we have focused on the relevance of squamous cell carcinoma, small cell lung cancer and large-cell neuroendocrine carcinoma transitions from adenocarcinoma resistant to TKIs.
Insights
Detecting epidermal growth factor receptor (EGFR) mutations is crucial for non-small cell lung cancer treatment. Morphological changes in cancer cells can indicate resistance to tyrosine kinase inhibitors (TKIs), highlighting the importance of cytopathology.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Targeted therapy with tyrosine kinase inhibitors (TKIs) is standard for advanced non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations.
- Identifying resistance mechanisms, including the p.T790M mutation, is essential for guiding subsequent treatment lines.
- Molecular testing alone may not identify all resistance mechanisms, necessitating complementary diagnostic approaches.
Purpose of the Study:
- To review the significance of morphological changes in NSCLC acquired resistance to TKIs.
- To emphasize the role of cytopathology in identifying resistance mechanisms.
- To discuss the transition of adenocarcinoma to other NSCLC subtypes (squamous cell carcinoma, small cell lung cancer, large-cell neuroendocrine carcinoma) upon TKI resistance.
Main Methods:
- Comprehensive literature review of studies on TKI resistance in NSCLC.
- Analysis of morphological alterations observed in cytopathological samples.
- Correlation of morphological changes with molecular resistance mechanisms.
Main Results:
- Acquired resistance to TKIs in NSCLC can manifest as significant morphological changes.
- These morphological changes can include transformation into squamous cell carcinoma, small cell lung cancer, or large-cell neuroendocrine carcinoma.
- Cytopathology can provide crucial diagnostic clues when molecular testing is inconclusive.
Conclusions:
- Morphological assessment via cytopathology is vital for diagnosing TKI resistance in NSCLC.
- Recognizing these phenotypic transitions is critical for appropriate patient management and treatment selection.
- Integrated diagnostic strategies combining molecular and morphological analyses improve outcomes for NSCLC patients.
Related Concept Videos
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Role of Hippocampus in Memory
Role-Based Identity
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Role of Amygdala in Memory
One of the...

